Cargando…
Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications
SIMPLE SUMMARY: The mortality of colorectal cancer is principally related to metastatic disease at the time of diagnosis or to the growth of initially undetectable micro-metastasis. Current therapeutic strategies are efficient in patients with locally advanced cancer, but are rarely able to cure pat...
Autores principales: | Amilca-Seba, Katyana, Sabbah, Michèle, Larsen, Annette K., Denis, Jérôme A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345080/ https://www.ncbi.nlm.nih.gov/pubmed/34359694 http://dx.doi.org/10.3390/cancers13153793 |
Ejemplares similares
-
Osteopontin (OPN/SPP1), a Mediator of Tumor Progression, Is Regulated by the Mesenchymal Transcription Factor Slug/SNAI2 in Colorectal Cancer (CRC)
por: Amilca-Seba, Katyana, et al.
Publicado: (2022) -
Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation
por: Moorman, Hannah R., et al.
Publicado: (2020) -
Role of osteopontin in tumour progression
por: Rittling, S R, et al.
Publicado: (2004) -
Human osteopontin: Potential clinical applications in cancer (Review)
por: Hao, Chengcheng, et al.
Publicado: (2017) -
Down-regulation of osteopontin attenuates breast tumour progression in vivo
por: Chakraborty, Goutam, et al.
Publicado: (2008)